$0.8012
-0.0083[-1.03%]
At close: Apr 16
$0.8012
0[0.00%]
PreMarket: 8:24AM EDT
Kezar Life Sciences
(NASDAQ:KZR)Latest News for Kezar Life Sciences Stock (NASDAQ:KZR)
Kezar Life Sciences Stock (NASDAQ: KZR)
Categories: All
Friday, March 15, 2024
Thursday, March 14, 2024
Tuesday, February 27, 2024
Monday, January 08, 2024
Monday, December 04, 2023
Monday, November 27, 2023
Tuesday, November 14, 2023
Monday, November 13, 2023
Friday, November 10, 2023
Thursday, October 12, 2023
Thursday, October 05, 2023
Wednesday, October 04, 2023
Tuesday, October 03, 2023
- Kezar Life Sciences Shares Resume TradeBenzinga Newsdesk - Oct 3, 2023, 4:40PM
- Kezar Will Explore Strategic Partnering Alternatives For Its Protein Secretion Platform And Preclinical ProgramsBill Haddad - Oct 3, 2023, 4:12PM
- Kezar Life Sciences Announces Restructuring To Prioritize Clinical-Stage Assets To Extend Capital For PALIZADE Phase 2b Trial In Lupus Nephritis; Will Reduce Workforce By 41%, All Research And Drug Discovery Activities PausedBill Haddad - Oct 3, 2023, 4:12PM
- Kezar Life Sciences Shares Halted, News PendingBill Haddad - Oct 3, 2023, 4:07PM
Monday, September 25, 2023
Thursday, September 21, 2023
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Sep 21, 2023, 12:08PM
- Market-Moving News for September 21stBenzinga Newsdesk - Sep 21, 2023, 8:37AM
- Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving PremarketLisa Levin - Sep 21, 2023, 7:51AM
- Kezar Life Sciences And Everest Medicines Collaborate To Bring Zetomipzomib To Patients With Lupus Nephritis And More Across Greater China, South Korea, And Southeast AsiaBenzinga Newsdesk - Sep 21, 2023, 1:16AM
Monday, September 11, 2023
Tuesday, August 22, 2023
Monday, August 21, 2023
Tuesday, August 15, 2023
Friday, August 11, 2023
- Stocks That Hit 52-Week Lows On FridayBenzinga Insights - Aug 11, 2023, 2:01PM
- Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Aug 11, 2023, 1:47PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Aug 11, 2023, 1:31PM
- Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023Benzinga Insights - Aug 11, 2023, 11:00AM
- Kezar Life Sciences shares are trading lower after the company reported a year-over-year decrease in Q2 EPS results. Also, Wells Fargo downgraded the stock from Overweight to Equal-Weight, while HC Wainwright lowered its price target from $19 to $18 on the stock.Benzinga Newsdesk - Aug 11, 2023, 10:30AM
- Wells Fargo Downgrades Kezar Life Sciences to Equal-WeightBenzinga Newsdesk - Aug 11, 2023, 9:47AM
- HC Wainwright & Co. Maintains Buy on Kezar Life Sciences, Lowers Price Target to $18Benzinga Newsdesk - Aug 11, 2023, 7:13AM
Thursday, August 10, 2023
Wednesday, August 09, 2023
Monday, August 07, 2023
Thursday, July 27, 2023
- Stocks That Hit 52-Week Lows On ThursdayBenzinga Insights - Jul 27, 2023, 12:17PM
- Kezar Life Sciences Director Acquires 52,000 Shares After Exercising Company Stock OptionsBenzinga Insights - Jul 27, 2023, 11:02AM
- Board Member at Kezar Life Sciences Exercises Options Worth $212KBenzinga Insights - Jul 27, 2023, 11:02AM
- Chief Financial Officer at Kezar Life Sciences Exercises Options Worth $1.69MBenzinga Insights - Jul 27, 2023, 11:02AM
- Kezar Life Sciences Director Acquires 78,689 Shares After Exercising Company Stock OptionsBenzinga Insights - Jul 27, 2023, 11:01AM
- Kezar Life Sciences Chief Medical Officer Acquires 980,000 Shares After Exercising Company Stock OptionsBenzinga Insights - Jul 27, 2023, 11:01AM
- Board Member at Kezar Life Sciences Exercises Options Worth $154KBenzinga Insights - Jul 27, 2023, 11:01AM
- Kezar Life Sciences CEO Acquires 2,655,000 Shares After Exercising Company Stock OptionsBenzinga Insights - Jul 27, 2023, 11:01AM
- Kezar Life Sciences Board Member Acquires 832,500 Shares After Exercising Company Stock OptionsBenzinga Insights - Jul 27, 2023, 11:01AM
- Board Member at Kezar Life Sciences Exercises Options Worth $230KBenzinga Insights - Jul 27, 2023, 11:01AM
- Kezar Life Sciences Chief Business Officer Awarded $631K Worth of Stock OptionsBenzinga Insights - Jul 27, 2023, 11:01AM
- Kezar Life Sciences Director Acquires 78,000 Shares After Exercising Company Stock OptionsBenzinga Insights - Jul 27, 2023, 11:01AM